Featured CME Topic: antibiotic resistance: Southern Medical Journal.Date of Original Release: October 1, 2003 Term of Approval: 1 Year * Credit Expires: October 1, 2004 Estimated Time for Completion: 1 Hour The following section was designed for physicians in all specialties, especially those in primary care. The Southern Medical Association is accredited accredited recognition by an appropriate authority that the performance of a particular institution has satisfied a prestated set of criteria. accredited herds cattle herds which have achieved a low level of reactors to, e.g. by the Accreditation Council for Continuing Medical Education The Accrediting Council for Continuing Medical Education (ACCME) is the overseeing body for continuing medical education (CME) in the United States. The ACCME sets the standards for the accreditation of all providers of CME activities. to sponsor continuing medical education continuing medical education See CME. for physicians. This CME CME See: Chicago Mercantile Exchange CME See Chicago Mercantile Exchange (CME). activity was planned and produced in accordance with the ACCME ACCME Accreditation Council for Continuing Medical Education Essentials. The Southern Medical Association designates this educational activity for a maximum of 1 Category 1 credit toward the AMA (Automatic Message Accounting) The recording and reporting of telephone calls within a telephone system. It includes the calling and called parties and start and stop times of the call. Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity. The Featured CME Topic is a CME activity developed and administered by the Southern Medical Association's Department of Education. To obtain Category 1 credit, follow the instructions at the end of the section. Purpose and Objectives Increasing antibacterial resistance among pathogens commonly associated with community-acquired respiratory tract infections has become a challenge to prescribers who must find more effective therapeutic strategies. Streptococcus pneumoniae Streptococcus pneu·mo·ni·ae n. Pneumococcus. Streptococcus pneumoniae Microbiology A pathogenic streptococcus with 90 serotypes associated with pneumonia, bacteremia, meningitis Transmission Person to person Incidence , Haemophilus influenzae Haemophilus in·flu·en·zae n. A gram-negative, rod-shaped bacterium of the genus Haemophilus, especially Haemophilus influenzae type b, that occurs in the human respiratory tract and causes acute respiratory infections, acute conjunctivitis, and , Moraxella catarrhalis, and Staphylococcus aureus Staphylococcus au·re·us n. A bacterium that causes furunculosis, pyemia, osteomyelitis, suppuration of wounds, and food poisoning. Staphylococcus aureus Staphylococcus pyogenes are among those exhibiting increased resistance to various antibacterial agents, thus limiting the available choices for effective treatment. The best antibiotic options are agents with a narrow spectrum of activity that are targeted at particular respiratory tract pathogens. After reading the following article, physicians will better understand the development, contributing factors, clinical and economic implications, and expected future advances in the area of antibacterial resistance. Disclosure In publishing this section in Southern Medical Journal, the Southern Medical Association recognizes educational needs of physicians in all specialties, especially those in primary care, for current information regarding antibiotic resistance. In this section, authors may have included discussions about drug interventions, whether approved or unapproved un·ap·proved adj. Not approved or sanctioned: an unapproved vaccine; an unapproved protest march. by the U.S. Food and Drug Administration. Therefore, it is incumbent on physicians reading this section to be aware of these factors in interpreting the contents and evaluating recommendations. Moreover, views of authors do not necessarily reflect the opinions of the Southern Medical Association. Every effort has been made to encourage the author to disclose any commercial relationships or personal benefit that may be associated with this section. If the author disclosed a relationship, it is indicated below. This disclosure in no way implies that the information presented is biased or of lesser quality, but allows participants to make informed judgments regarding program content. Disclaimer The primary purpose of this section in the Journal is education. Information presented and techniques discussed are intended to inform physicians of medical knowledge, clinical procedures, and experiences of physicians willing to share such information with colleagues. It is recognized that a diversity of professional opinions exists in the contemporary practice of medicine that influences the selection of methods and procedures. The views and approaches of authors are offered solely for educational purposes. The Southern Medical Association disclaims any and all liability for injury or other damages to any individual reading this section and for all claims that may result from the use of techniques and procedures presented in it. Paul Iannini, MD Grant/Research Support: Aventis Pharmaceuticals Consultant: Speaker's Bureau: Stock Shareholder: Other Support: |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion